ClearPoint Neuro (CLPT) Share-based Compensation Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.54% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.09% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.29% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 7.15% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 13.40% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.36% |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | 19.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.28% |
| Dec 31, 2025 | 19.12% |
| Sep 30, 2025 | 19.83% |
| Jun 30, 2025 | 37.13% |
| Mar 31, 2025 | 28.51% |
| Dec 31, 2024 | 22.56% |
| Sep 30, 2024 | 48.11% |
| Jun 30, 2024 | 93.73% |
| Mar 31, 2024 | 67.51% |
| Dec 31, 2023 | 67.56% |
| Sep 30, 2023 | 75.51% |
| Jun 30, 2023 | 89.69% |
| Mar 31, 2023 | 78.97% |
| Dec 31, 2022 | 73.87% |
| Sep 30, 2022 | 74.95% |
| Jun 30, 2022 | 62.79% |
| Mar 31, 2022 | 80.61% |
| Dec 31, 2021 | 52.10% |
| Sep 30, 2021 | 41.19% |
| Jun 30, 2021 | -4.45% |
| Mar 31, 2021 | 8.95% |
| Sep 30, 2019 | -2.69% |
| Jun 30, 2019 | -5.05% |
| Mar 31, 2019 | -7.40% |
| Sep 30, 2018 | -8.17% |
| Jun 30, 2018 | -28.49% |
| Mar 31, 2018 | -13.16% |
| Sep 30, 2016 | -11.68% |
| Jun 30, 2016 | -9.74% |
| Mar 31, 2016 | -15.50% |
| Sep 30, 2015 | -3.62% |
| Jun 30, 2015 | 35.15% |
| Mar 31, 2015 | 18.02% |
| Dec 31, 2014 | -45.87% |
| Sep 30, 2014 | -8.24% |
| Jun 30, 2014 | -10.15% |
| Mar 31, 2014 | -10.97% |